Skip to main
ESTA

ESTA Stock Forecast & Price Target

ESTA Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 43%
Buy 43%
Hold 14%
Sell 0%
Strong Sell 0%

Bulls say

Establishment Labs Hldgs is a leading medical technology company with a strong global presence and a unique product offering in the form of the Motiva breast implant. With its impressive safety profile, natural feel, and disruptive technology, Establishment Labs has the potential to capture market share from established players in markets like the U.S. and China. Additionally, the company's minimally invasive platform and new pipeline developments are expected to drive long-term growth. With strong early demand for new products like Preservé, Establishment Labs looks well-positioned for continued success, as evidenced by its recent strong quarterly results and increased revenue guidance for 2026.

Bears say

Establishment Labs Hldgs is currently experiencing strong financial growth due to their innovative R&D and numerous market-expanding catalysts, leading to a Buy rating and an $88 price target. However, the company faces several risks, such as potential funding needs and the possibility of unsuccessful pipeline product launches, which could impact their financial performance and stock value. Additionally, competition and economic recessions may also pose risks for the company.

ESTA has been analyzed by 7 analysts, with a consensus rating of Buy. 43% of analysts recommend a Strong Buy, 43% recommend Buy, 14% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Establishment Labs Holdings Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Establishment Labs Holdings Inc (ESTA) Forecast

Analysts have given ESTA a Buy based on their latest research and market trends.

According to 7 analysts, ESTA has a Buy consensus rating as of Jul 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $90.43, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $90.43, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Establishment Labs Holdings Inc (ESTA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.